Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis
Top Cited Papers
Open Access
- 11 June 2018
- journal article
- research article
- Published by S. Karger AG in Liver Cancer
- Vol. 8 (2), 121-129
- https://doi.org/10.1159/000488778
Abstract
Background/Aim: The frequency of hepatocellular carcinoma (HCC) in patients with good hepatic reserve function has been increasing in Japan along with the progression of antiviral therapies and aging of the society. We evaluated the usefulness of modified albumin-bilirubin (ALBI) grade as a tool for assessment of hepatic reserve function. Materials/Methods: We enrolled 6,649 naïve HCC patients treated from 2000 to 2017 and divided them into training (Ehime Prefecture group: E group, n = 2,357) and validation (validation group: V group, n = 4,292) cohorts. Child-Pugh classification and ALBI and modified ALBI (mALBI) grading were compared using with Japan Integrated Staging (JIS), ALBI-TNM (ALBI-T), and mALBI-T scores, which were calculated based on TNM stage and each assessment tool, retrospectively. Results: In the E group, Akaike’s Information Criterion (AIC) and c-index values for mALBI-T (13,725.2/0.744) were better as compared to those of ALBI-T (13,772.6/0.733) and JIS score (13,874.7/0.720), with similar results observed in the V group (mALBI-T: 27,727.4/0.760; ALBI-T: 27,817.8/0.750; JIS: 27,807.5/0.748). Although there were some significant differences between the groups with regard to clinical background factors (age, etiology, tumor size, tumor number, treatment modalities), for all patients the AIC and c-index values of mALBI-T (45,327.1/0.755) were also better than those of ALBI-T (45,467.7/0.744) and JIS scores (45,555.8/0.739), indicating its superior stratification ability and prognostic predictive value in patients with HCC. Conclusion: The detailed stratification ability of mALBI grade for hepatic reserve function is suitable for the recent trend of HCC patients, while mALBI-T may provide a more accurate predictive value than existing total staging scoring systems.Keywords
This publication has 34 references indexed in Scilit:
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infectionHepatology, 2010
- Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.2009
- Assessment of liver function for safe hepatic resectionHepatology Research, 2009
- Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in JapanHepatology Research, 2007
- Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan†Hepatology Research, 2007
- Management of hepatocellular carcinomaHepatology, 2005
- Efficacy of lamivudine therapy for decompensated liver cirrhosis due to hepatitis B virus with or without hepatocellular carcinomaOncology Reports, 2005
- Percutaneous radiofrequency ablation for hepatocellular carcinomaCancer, 2005
- Validation of a new prognostic staging system for hepatocellular carcinoma: The JIS score compared with the CLIP scoreHepatology, 2004
- Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)The Esophagus, 2003